These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Laragh JH, Baer L, Brunner HR, Buhler FR, Sealey JE, Vaughan ED. Am J Med; 1972 May; 52(5):633-52. PubMed ID: 4337477 [No Abstract] [Full Text] [Related]
24. A sibship with Bartter's syndrome: failure of total adrenalectomy to correct the potassium wasting. Trygstad CW, Mangos JA, Bloodworth JM, Lobeck CC. Pediatrics; 1969 Aug; 44(2):234-42. PubMed ID: 4308821 [No Abstract] [Full Text] [Related]
25. [Pathophysiological aspects of the renin-angiotensin-aldosterone system]. Oelkers W. Verh Dtsch Ges Kreislaufforsch; 1977 Aug; 43():145-56. PubMed ID: 349923 [No Abstract] [Full Text] [Related]
27. Laxative-induced hypokalemia, sodium depletion and hyperreninemia. Effects of potassium and sodium replacement on the renin-angiotensin-aldosterone system. Fleming BJ, Genuth SM, Gould AB, Kamionkowski MD. Ann Intern Med; 1975 Jul; 83(1):60-2. PubMed ID: 1147438 [Abstract] [Full Text] [Related]
28. Hypertension, hypokalemia and hypoaldosteronism with suppressed renin: a clinical study of a patient with Liddle's syndrome. Sakamoto N, Uda M, Kojima S, Tsuchiya M, Ito K, Ogino K, Ikeda M, Watabe R. Endocrinol Jpn; 1981 Jun; 28(3):357-62. PubMed ID: 6273144 [Abstract] [Full Text] [Related]
29. Secondary aldosteronism: with observations on the definition of hypokalemia. Kaplan NM. Am J Clin Pathol; 1970 Sep; 54(3):316-23. PubMed ID: 4319208 [No Abstract] [Full Text] [Related]
30. The effect of triamterene and sodium intake on renin, aldosterone, and erythrocyte sodium transport in Liddle's syndrome. Wang C, Chan TK, Yeung RT, Coghlan JP, Scoggins BA, Stockigt JR. J Clin Endocrinol Metab; 1981 May; 52(5):1027-32. PubMed ID: 6262354 [Abstract] [Full Text] [Related]
31. Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin. Brown JJ, Davies DL, Ferriss JB, Fraser R, Haywood E, Lever AF, Robertson JI. Br Med J; 1972 Jun 24; 2(5816):729-34. PubMed ID: 4338668 [Abstract] [Full Text] [Related]
32. Hypokalemia and alkalosis in adipsic hypernatremia are not associated with hyperaldosteronism. Torchinsky MY, Deputy S, Rambeau F, Chalew SA. Horm Res; 2004 Jun 24; 62(4):187-90. PubMed ID: 15452384 [Abstract] [Full Text] [Related]
33. [The Bartter syndrome and the pseudo-Bartter syndrome]. Trübestein GK, Werning C, Stadelmann O, Kuhlmann U, Stiel D, Schweikert HU, Siegenthaler W. Munch Med Wochenschr; 1972 Apr 07; 114(14):635-40. PubMed ID: 4338788 [No Abstract] [Full Text] [Related]
34. [Recent knowledge of diseases with abnormal aldosterone secretion]. Kono T. Naika Hokan; 1971 Jan 07; 18(1):25-48. PubMed ID: 4926145 [No Abstract] [Full Text] [Related]
35. Hypokalemic metabolic alkalosis in normotensive infants with elevated plasma renin activity and hyperaldosteronism: role of dietary chloride deficiency. Roy S, Arant BS. Pediatrics; 1981 Mar 07; 67(3):423-9. PubMed ID: 7017580 [Abstract] [Full Text] [Related]
36. Aldosterone escape to chronic ACTH administration in man. Gaillard RC, Riondel AM, Favrod-Coune CA, Vallotton MB, Muller AF. Acta Endocrinol (Copenh); 1983 May 07; 103(1):116-24. PubMed ID: 6305073 [No Abstract] [Full Text] [Related]
37. Bartter's syndrome. New insights into pathogenesis and treatment. Solomon RJ, Brown RS. Am J Med; 1975 Oct 07; 59(4):575-83. PubMed ID: 1166859 [Abstract] [Full Text] [Related]
39. Renin-aldosterone profiling in hypertension. Mitchell JR, Taylor AA, Pool JL, Lake CR, Rollins DE, Bartter FC. Ann Intern Med; 1977 Nov 07; 87(5):596-312. PubMed ID: 335942 [Abstract] [Full Text] [Related]